O
Oramed Pharmaceuticals Inc. (ORMP)
NCM – Real Time Price. Currency in USD
4.45
-0.17 (-3.68%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
4.45
-0.17 (-3.68%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $45.9M significantly exceed its total debt $825.0K, ensuring strong financial flexibility
Total current assets $133.3M exceed Total current liabilities $19.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$626.5K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.98 | 6.05 | 10 | |
| Quick ratio | 6.98 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 1M | N/A | 2M | 2M |
| Gross Profit | N/A | N/A | -193K | 13K | -108K |
| Operating Income | -41M | -16M | -13M | -15M | -15M |
| Net Income | -37M | 6M | -19M | 63M | 63M |
| EBITDA | -41M | -16M | -13M | -15M | -15M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | -100 | -197.67 | 1.0 |
| Next year | N/A | 34.92 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -80.98 | N/A | 68.54 | 5.5 |
| Y/Y | 999 | 190.3 | 100 | 67.81 | 10 |
| 3y average | 282.86 | 33.98 | 9.26 | 25.13 | 9.0 |
| 5y average | 169.67 | -11.12 | -6 | -6.43 | 3.3 |
| Weighted average score | 7.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |